Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fourie

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Nature|April 1, 2005
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitroHeather Stanton, Fraser M Rogerson, Charlotte J East, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2020
Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approachChristoph Steeneck, Christian Gege, Olaf Kinzel, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2020
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγtChristian Gege, Michael Albers, Olaf Kinzel, et al.
Scientific Reports|December 2, 2016
Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritisXiaohua Xue, Pejman Soroosh, Aimee De Leon-Tabaldo, et al.
Journal of Medicinal Chemistry|July 1, 2008
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activityCheryl A Grice, Kevin L Tays, Brad M Savall, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2019
3-Substituted Quinolines as RORγt Inverse AgonistsVirginia M Tanis, Hariharan Venkatesan, Maxwell D Cummings, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2017
Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγtDavid A Kummer, Maxwell D Cummings, Marta Abad, et al.
Journal of Medicinal Chemistry|April 16, 2025
Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of PsoriasisOlaf Kinzel, Steven D Goldberg, Maxwell D Cummings, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2012
Azabenzthiazole inhibitors of leukotriene A₄ hydrolaseVirginia M Tanis, Genesis M Bacani, Jonathan M Blevitt, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2017
6-Substituted quinolines as RORγt inverse agonistsJ Kent Barbay, Maxwell D Cummings, Marta Abad, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Nature|April 1, 2005
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitroHeather Stanton, Fraser M Rogerson, Charlotte J East, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2020
Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approachChristoph Steeneck, Christian Gege, Olaf Kinzel, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2020
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγtChristian Gege, Michael Albers, Olaf Kinzel, et al.
Scientific Reports|December 2, 2016
Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritisXiaohua Xue, Pejman Soroosh, Aimee De Leon-Tabaldo, et al.
Journal of Medicinal Chemistry|July 1, 2008
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activityCheryl A Grice, Kevin L Tays, Brad M Savall, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2019
3-Substituted Quinolines as RORγt Inverse AgonistsVirginia M Tanis, Hariharan Venkatesan, Maxwell D Cummings, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2017
Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγtDavid A Kummer, Maxwell D Cummings, Marta Abad, et al.
Journal of Medicinal Chemistry|April 16, 2025
Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of PsoriasisOlaf Kinzel, Steven D Goldberg, Maxwell D Cummings, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2012
Azabenzthiazole inhibitors of leukotriene A₄ hydrolaseVirginia M Tanis, Genesis M Bacani, Jonathan M Blevitt, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2017
6-Substituted quinolines as RORγt inverse agonistsJ Kent Barbay, Maxwell D Cummings, Marta Abad, et al.
Pageof 3